← Search
TV

Travere Therapeutics, Inc. TVTX

NASDAQ
Latest Close (2026-08-26)
$67.01
Market Cap
$6,316,435,105
Cash on Hand
$117,735,000
Quarterly Burn
$40,366,000
Cash Runway
8.8 mo
Risk Score
N/A
Insider Ownership
N/A
Loading chart…

Recent News

Travere Therapeutics stock hits 52-week high at 66.35 USD
Investing.com · 2026-08-21
TVTX | Travere Therapeutics, Inc. Common Financials - Revenue Breakdown
Quiver Quantitative · 2026-08-23
Travere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease
Stocktwits · 2026-08-21
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?
Yahoo Finance · 2026-06-13
Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On
Benzinga · 2026-08-05
Headlines via Google News, linking to original publishers. We don't host or republish article content.

History

Total raised (where amount could be determined): $0
Unclassified: $0
DateFiling TypeOffering TypeAmountSharesSource
2026-05-07 Shelf/ATM Filing - - filing →
2026-05-05 Shelf/ATM Filing - - filing →
2024-11-08 Shelf/ATM Filing - - filing →
2024-11-07 Shelf/ATM Filing - - filing →
2024-10-31 Shelf/ATM Filing - - filing →
2023-03-01 Shelf/ATM Filing - - filing →
2023-02-27 Shelf/ATM Filing - - filing →
2022-03-09 Shelf/ATM Filing - - filing →
2022-03-08 Shelf/ATM Filing - - filing →
2021-02-12 Shelf/ATM Filing - - filing →

No stock split events on file.

Same Sector

Upstream Bio, Inc. (UPB) UPB Trevi Therapeutics, Inc. (TRVI) TRVI Neuphoria Therapeutics Inc. (NEUP) NEUP Nuvation Bio Inc. (NUVB) NUVB BELITE BIO, INC (BLTE) BLTE